Invitrogen™ Kit ELISA d

Ref.: BL-RE-090734Manufacturer ref.: ESH3RBX10 10 x 96 tests
Price on request
Custom pricing depending on configuration and quantity.

The interleukine-17A (IL-17A, CTLA-8) is a cytokine derived from CD4+ T-cells that promotes inflammatory responses in cell lines and is elevated in rheumatoid arthritis, asthma, multiple sclerosis, psoriasis and psoriasis.

Accession number
Q13316
Dose range
0.45 to 100 pg/ml
Sensitivity of the dosage
0.45 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

The interleukine-17A (IL-17A, CTLA-8) is a cytokine derived from CD4+ T-cells that promotes inflammatory responses in cell lines and is elevated in rheumatoid arthritis, asthma, multiple sclerosis, psoriasis and psoriasis.

The interleukine-17A (IL-17A, CTLA-8) is a cytokine derived from CD4+ T cells that promotes inflammatory responses in cell lines and is elevated in rheumatoid arthritis, asthma, multiple sclerosis, psoriasis and transplant rejection. The IL-17A is a long homodimer bound to 32 kDa disulfide composed of 136 amino acids that are part of a family of proteins of six species (IL-17A-17F) and signals via the IL-17 receptor (IL-17R / CDw217). High levels of IL-17A homodomer are produced by activated peripheral blood CD4+ T cells, and the IL-17A also improves the expression of intracellular 1-adhesion molecule (ICAM-1) in human fibroblasts. In particular, human L-IL-17A also stimulates epithelial, endothelial, or fibroblast cells to secrete the Z-IL-6, Z-IL-8, G-CSF, and PGE2. In the presence of human IL-17A, fibroblasts can support the proliferation of CD34 + haematopoietic progenitors and induce neutrophil maturation. Human, mouse, and rat L-IL-17A may induce secretion of IL-6 in stromal mouse cells, indicating that all homologues can recognize the mouse receptor. The IL-17A regulates mitogen-activated protein kinase activity and NF-kappa B, stimulates expression of IL-6 and cyclooxygenase-2 (PTGS2 / COX-2) and improves nitric oxide production (NO).

Sensitivity

Sensitivity of dosage: 0.45 pg/ml.

Measurement range

Dose range: 0.45 to 100 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: IL-17 A.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17738283
Specifications
Accession numberQ13316
Dose range0.45 to 100 pg/ml
Sensitivity of the dosage0.45 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)101103931
Gene symbol(s)IL17A
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated sheetings, etc., at the same time as the pre-casting plate, at the same time as the pre-casting plate.
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetIL-17 A
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 μl-Surnatant, 50 μl-Serum, 50 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ESH3RBX10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.